Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MOVE logo MOVE
Upturn stock ratingUpturn stock rating
MOVE logo

Movano Inc (MOVE)

Upturn stock ratingUpturn stock rating
$0.76
Last Close (24-hour delay)
Profit since last BUY-27.62%
upturn advisory
WEAK BUY
BUY since 8 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/12/2025: MOVE (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $30

1 Year Target Price $30

Analysts Price Target For last 52 week
$30 Target price
52w Low $0.51
Current$0.76
52w High $6.97

Analysis of Past Performance

Type Stock
Historic Profit -48.01%
Avg. Invested days 23
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.31M USD
Price to earnings Ratio -
1Y Target Price 30
Price to earnings Ratio -
1Y Target Price 30
Volume (30-day avg) 1
Beta 0.94
52 Weeks Range 0.51 - 6.97
Updated Date 09/13/2025
52 Weeks Range 0.51 - 6.97
Updated Date 09/13/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.94

Earnings Date

Report Date 2025-08-18
When After Market
Estimate -0.7
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -4227.03%

Management Effectiveness

Return on Assets (TTM) -145.98%
Return on Equity (TTM) -439.23%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -1402935
Price to Sales(TTM) 6.23
Enterprise Value -1402935
Price to Sales(TTM) 6.23
Enterprise Value to Revenue 22.15
Enterprise Value to EBITDA -1.24
Shares Outstanding 8301200
Shares Floating 5749331
Shares Outstanding 8301200
Shares Floating 5749331
Percent Insiders 24.94
Percent Institutions 15.13

ai summary icon Upturn AI SWOT

Movano Inc

stock logo

Company Overview

overview logo History and Background

Movano Inc., founded in 2010, focuses on developing non-invasive health monitoring solutions using radio frequency (RF) technology. It aims to bring affordable and accessible health tracking to a broader consumer base.

business area logo Core Business Areas

  • Non-Invasive Health Monitoring: Development and commercialization of wearable devices and associated services for continuous health data tracking. Key focus areas include heart rate, sleep, blood glucose and blood pressure monitoring.

leadership logo Leadership and Structure

Dr. John Mastrototaro is the CEO. The company has a management team focused on engineering, product development, and regulatory affairs. The organizational structure is typical for a development-stage medical device company.

Top Products and Market Share

overview logo Key Offerings

  • Evie Ring: A smart ring designed to track various health metrics, including heart rate, heart rate variability, SpO2, sleep stages, activity, menstrual cycles, and mood. Market share is currently negligible as the product is in the early stages of launch. Competitors include Oura, Ultrahuman, and Circular.

Market Dynamics

industry overview logo Industry Overview

The health and wellness wearable market is experiencing significant growth, driven by increasing consumer interest in personal health monitoring. The market is competitive, with numerous players offering a variety of devices and services.

Positioning

Movano aims to differentiate itself by offering accurate, non-invasive measurements and focusing on affordability and accessibility. They are competing against established players with larger market shares.

Total Addressable Market (TAM)

The global wearable medical device market is projected to reach approximately $30 billion by 2028. Movano is positioned to capture a portion of this TAM, targeting the consumer health and wellness segment.

Upturn SWOT Analysis

Strengths

  • Novel RF-powered sensor technology
  • Focus on non-invasive and continuous monitoring
  • Potential for affordable health tracking
  • Strong patent portfolio

Weaknesses

  • Limited market presence
  • Dependence on successful product development and regulatory approval
  • Intense competition in the wearable market
  • History of net losses

Opportunities

  • Growing demand for wearable health monitoring devices
  • Expansion into new markets and applications
  • Partnerships with healthcare providers and insurers
  • Advancements in sensor technology and data analytics

Threats

  • Competition from established players with greater resources
  • Regulatory hurdles and clinical validation requirements
  • Rapid technological advancements and changing consumer preferences
  • Economic downturns impacting consumer spending

Competitors and Market Share

competitor logo Key Competitors

  • FIT
  • WHOOP
  • ORNB

Competitive Landscape

Movano faces intense competition from established players like Fitbit and Oura, requiring them to demonstrate a clear competitive advantage in terms of accuracy, features, and affordability.

Growth Trajectory and Initiatives

Historical Growth: Movano's historical growth has been characterized by R&D progress and clinical trials, rather than revenue generation.

Future Projections: Future growth depends on successful commercialization of the Evie Ring and other planned products, with analyst estimates varying widely.

Recent Initiatives: Recent initiatives include the launch of the Evie Ring, the completion of clinical studies, and continued development of RF sensor technology.

Summary

Movano Inc. is a development-stage company with innovative RF sensor technology, targeting the growing wearable health market. A major advantage the company has is their patent portfolio, however their ability to compete depends on successful product launches. Intense competition and regulatory hurdles pose significant challenges to Movanou2019s long-term success. Therefore, for the company to succeed it needs to show strong performance in upcoming clinical trials, and a successful launch and reception of the new Evie ring

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (SEC)
  • Market research reports
  • Analyst estimates
  • Movano Inc. Investor Relations

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Movano Inc

Exchange NASDAQ
Headquaters Pleasanton, CA, United States
IPO Launch date 1999-08-05
CEO, President & Director Dr. John Mastrototaro Ph.D.
Sector Healthcare
Industry Medical Devices
Full time employees 32
Full time employees 32

Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.